DCCPS- Surveillance Research Program

DCCPS-监视研究计划

• 批准号: 10038366
• 负责人: LEONARD FREEDMAND
• 金额: $ 41.86万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-31 至 2020-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10038366
• 关键词: Cancer Surveillance Research Program; Collection; Data; Data Collection; Division of Cancer Control and Population Sciences; Ensure; Fostering; Modeling; Outcome; Pharmacy facility; Process; Residual state; SEER Program; Tissues; Trust; improved; new technology; repository

Abstract - As the SEER programs continue to expand (in quality, expanded outcomes collection, and utilization) it is critical to establish a model and a set of processes for ensuring confidence and trust in the use and application of the SEER data. This is particularly critical as SEER approaches potential opportunities to: 1) integrate new technologies to curate date (e.g., NLP), 2) improve quality and efficiency of existing platforms, 3) expand the scope of data collection (e.g., Residual Tissue Repository), and 4) foster new partnerships with other organizations (e.g., commercial pharmacy chains).

随着SEER项目的不断扩大（在质量、结果收集和利用方面的扩大），建立一个模型和一套流程来确保对SEER数据的使用和应用的信心和信任是至关重要的。这一点尤其重要，因为SEER正在接近以下潜在机会：1)整合新技术来管理数据（例如，NLP）， 2)提高现有平台的质量和效率，3)扩大数据收集的范围（例如，残余组织存储库），以及4)与其他组织（例如，商业药房连锁店）建立新的合作伙伴关系。